menu
    • menu

    Company profile for Barinthus Biotherapeutics

    NEW Drugs in Dev: 13
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Barinthus Biotherapeutics plc (formerly Vaccitech plc) is a clinical-stage biopharmaceutical company dedicated to developing novel T-cell immunotherapeutics. The company's focus is on guiding the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Barinthus Biotherapeutics has a broad pipeline, characterized by four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Barinthus Biotherapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Unit 6-10 Zeus Building Rutherford Avenue Harwell OX11 0DF
    Telephone
    Telephone
    +44 (0)1865 818808
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.barinthusbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/barinthusbiotherapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Barinthus Bio Unveils Q1 2026 Financials And Corporate Progress
    Barinthus Bio Unveils Q1 2026 Financials And Corporate Progress

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3284725/0/en/barinthus-bio-reports-first-quarter-2026-financial-results-and-updates-on-corporate-developments.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    Barinthus Bio Unveils 2025 Financials And Corporate Progress
    Barinthus Bio Unveils 2025 Financials And Corporate Progress

    13 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/13/3255444/0/en/Barinthus-Bio-Reports-Full-Year-2025-Financial-Results-and-Updates-on-Corporate-Developments.html

    GLOBENEWSWIRE
    13 Mar 2026
    Share Share
    Barinthus Bio Updates Phase 1 Celiac Trial of VTP-1000
    Barinthus Bio Updates Phase 1 Celiac Trial of VTP-1000

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203120/0/en/Barinthus-Bio-Announces-Update-on-Phase-1-AVALON-Clinical-Trial-of-VTP-1000-for-the-Treatment-of-Celiac-Disease.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share
    Barinthus Bio Updates Q3 2025 Financials And Corporate Progress
    Barinthus Bio Updates Q3 2025 Financials And Corporate Progress

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183569/0/en/Barinthus-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Updates-on-Corporate-Developments.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Barinthus to Merge with Clywedog in Autoimmune, Metabolic Disease
    Barinthus to Merge with Clywedog in Autoimmune, Metabolic Disease

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158744/0/en/Barinthus-Biotherapeutics-to-Combine-with-Clywedog-Therapeutics-to-Target-Metabolic-and-Autoimmune-Diseases.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    Barinthus Bio Updates on Corporate Developments, Q2 2025
    Barinthus Bio Updates on Corporate Developments, Q2 2025

    07 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/07/3129180/0/en/Barinthus-Bio-Reports-Second-Quarter-2025-Financial-Results-and-Updates-on-Corporate-Developments.html

    GLOBENEWSWIRE
    07 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search